PCN Insights, News, Videos, and More

Preexisting psychological distress is linked with a heightened risk of developing COVID-19-related symptoms lasting 4 weeks or more, so-called “long COVID,” suggest findings published online in JAMA Psychiatry.

In patients with schizophrenia-spectrum disorders, continuing antipsychotic treatment at standard doses or switching to a different antipsychotic are similar in prevention of relapse, according to a network meta-analysis.

LSD-assisted therapy was found to produce long-lasting and notable reductions of anxiety and comorbid symptoms of depression for up to 16 weeks in a study conducted by Swiss researchers.

Major treatment failure occurred at a lower rate in patients with recent-onset schizophrenia or schizophreniform disorder treated with the long-acting injectable (LAI) antipsychotic paliperidone palmitate (PP) compared with oral...

Researchers also found that younger adults and males are more susceptible than older adults and females.

Low-dose ketamine was safe, well-tolerated, and effective in treating clinical symptoms in children diagnosed with ADNP syndrome, a rare neurodevelopmental disorder, in a study conducted by researchers at Mount Sinai’s Seaver Autism Center.

The anxiety-easing effects of exercise do not appear to differ between individuals, according to study findings published online ahead of print in Psychiatry Research.

Traumatic brain injury (TBI) and post-traumatic stress disorder (PTSD) were associated with an increased prevalence of mild cognitive impairment but not Alzheimer disease biomarkers in a study of Vietnam veterans, according to a new study...